aod9604 oral AOD 9604 With Retatrutide: Evidence, Safety, and UK Regulatory Status – Bolt Pharmacy Peptide Therapy - Optimum Peak
Description
Pro-inflammatory macrophages increase in skeletal muscle of high fat-fed mice and correlate with metabolic risk markers in humans
A subsequent study, doubling the length of the original at 24 weeks, found no significant weight loss in the study group
In those patients, addressing the underlying metabolic dysfunction first, through dietary intervention, GLP-1 therapy if indicated, or NAD+ support for cellular energy metabolism, is the clinical priority
References Neelakantan H, et al
The peptide works by selectively activating lipolysis (fat breakdown) in adipose tissue while inhibiting lipogenesis (fat storage)
